Ron Travaglino - PowerPoint PPT Presentation

About This Presentation
Title:

Ron Travaglino

Description:

Vegetarians. Jehovah's Witnesses and Associates - World Population. 1985 - 7,792,109 ... Acid (1 mg/day) Vitamin B-12. Ascorbic Acid (500 mg/day) Iron (Oral or ... – PowerPoint PPT presentation

Number of Views:121
Avg rating:3.0/5.0
Slides: 53
Provided by: rxtr
Learn more at: http://www.imiaweb.org
Category:

less

Transcript and Presenter's Notes

Title: Ron Travaglino


1
Ron Travaglino Director
2
Accommodating Patients Requests For Medical
Treatment Without Allogeneic Blood
3
Bloodless Medicine and Surgery Defined
  • Use of New and Existing Techniques, Procedures,
    Technology, and Equipment to reduce or eliminate
    the need to use allogeneic (donor) blood

4
Englewood Hospital Medical Center Bloodless
Institute
  • Patients from 40 States in USA
  • Patients from 40 Countries
  • Major Cardiac, Orthopedic, Vascular,
    Neurological, Gynecological, Hepatic, Thoracic,
    Urologic Surgery
  • Hundreds of Transfers from Other Hospitals
    including those claiming to be Bloodless
    Centers

5
Bloodless Medicine and Surgery - A
Multidisciplinary Effort
  • Surgeons
  • Anesthesia Personnel
  • Nurses
  • Internists
  • Hematologists
  • Administrators
  • Ancillary Staff
  • Pharmacy
  • Lab
  • Blood Bank

6
Englewood Hospital and Medical Center-Bloodless
Institute
  • 200 Physicians
  • Six dedicated staff members
  • Patient Intake and care coordination
  • Patient Education, Advance Directives
  • Preoperative patient preparation
  • Patient Advocacy
  • Four Medical Directors
  • Regular nursing, physician, staff education
  • Regular community education

7
Bloodless Medicine and Surgery Why?
  • Crisis in Blood Supply and Availability
  • Blood Borne Disease Risks
  • Patient refusal/reluctance
  • Cost Considerations

8
Bloodless Medicine and Surgery - Why?
  • Patients choice
  • Blood is a precious fluid
  • Increasing Elderly Population
  • By 2030, annual shortfall of 4 million units in
    USA
  • Less than 5 of eligible population donates in
    USA
  • Blood Transfusion is associated with Significant
    Cost

9
Reasons That Support Bloodless Medicine and
Surgery
  • Blood therapy is expensive-proven risks and
    hazards
  • Public health concerns
  • Shortage of blood nationally
  • Medical devices and pharmaceuticals facilitate
    bloodless care
  • No significant increase of morbidity and
    mortality
  • Overall decrease in healthcare costs
  • Enhances practical clinical experience
  • Growing patient population supplies data for more
    education
  • Supports patients rights and autonomy
  • Good economics

10
Who are the Patients?
  • Religious Motivation
  • Primarily Jehovahs Witnesses
  • Non - Religious Motivation
  • Concern over blood safety
  • Personal/Family Member History of Problematic
    Transfusion
  • Vegetarians

11
Jehovahs Witnesses and Associates - World
Population
  • 1985 - 7,792,109
  • 1995 - 13,147,201
  • 2000 - 14,872,086
  • 2007 - 16,675,113

12
Jehovahs Witnesses
  • Do Not Refuse Medical Care
  • - only blood transfusions
  • Refusal of Blood not a RIGHT TO DIE Issue
  • Actively Pursue Non Blood Medical Management

13
Jehovahs Witnesses Do Accept
  • Various Surgical, Medical, Anesthesia, Nursing
    Modalities to Conserve/Preserve Blood
  • All Other Types of Standard Medical Care

14
(No Transcript)
15
Fractional Components
  • Medical/Scientific
  • Line of Reasoning
  • Realistic consideration of physical Risks vs.
    Benefits
  • Conscientious Line of Reasoning
  • Thoughtful consideration of other Risks vs.
    Benefits
  • (i.e. spiritual)

16
Blood Fractions - Examples
  • ALBUMIN (EPO)
  • IMMUNE GLOBULINS
  • CLOTTING FACTORS (some)
  • CRYOPRECIPTATES
  • HEMOGLOBIN BASED PRODUCTS
  • More and More Available

17
Making the Decisions - Medical Line of Reasoning
  • Blood Fractions are fundamental tools in hands of
    Physicians
  • Many non blood alternatives fit into these
    categories
  • Some used only in the face of imminent loss of
    life, so small risk of disease is tolerable

18
Accommodating PatientsLegal and Ethical
Principles
  • Bodily Self Determination
  • Upheld by US Supreme Court and State Courts
  • Right to Refuse Treatment
  • Special Considerations for Minors

19
Risks of Blood Transfusions
  • Incompatibility
  • (ABO and other groups)
  • Infectious complications
  • Immunomodulatory
  • Resource availability
  • Risk to Benefit Ratio

20
Blood Collection and Transfusion - US in 1999
  • 13,225,000 allogeneic units collected
  • 12,020,000 allogeneic units transfused
  • 226,000 lost to screening (1.7)
  • 787,000 outdated (5.9)
  • 112/1709 (6.6) of hospitals cancelled surgery
    because of no blood

21
(No Transcript)
22
Transfusion Behavior (Survey) 1997
  • US physicians 100 MDs all specialists.
  • At what Hb. would you be transfused?
  • Hb. of 9 gms/dl 0
  • Hb. of 7 gms/dl /-5
  • Hg. of 5 gms/dl /-14
  • Lower? /-19.5
  • gt 78 have Tx. Patients with Hb. 9.0 gms
  • Role of guidelines in Transfusion Medicine Bifano
    et.al.

23
Bloodless Institute Risk Management
  • No Legal Cases or Consequences attributable to
    Bloodless Program
  • Patients sign Release of Liability Form on
    admission
  • No change in Hospitals Liability Insurance
    Coverage

24
Hospital Liability?
  • The court allowed the plaintiff's negligence
    action against the hospital for not having given
    recipient notice of the danger of transfusions.
  • Estate of Jane Doe v. Vanderbilt University, Inc.
    1993

25
Bloodless Care and Cost Savings
  • Cost of acquiring ONE unit of Packed Red Blood
    Cells is approximately 225 US
  • TRUE cost much higher (transport, storage,
    administration, potential complications)
  • Study found allogeneic transfusions associated
    with 1000-1500 US incremental Hospital costs

26
Management of Anemia
  • Careful Evaluation and Diagnosis
  • Accurate History and Physical
  • Avoid and/or Manage Preoperatively if at all
    Possible
  • Recombinant Human Erythropoietin (Epoetin Alfa)

27
EPO DOSING REGIMEN
  • 300-600 Units/Kilogram, from three to ten weeks
    before Surgery, Subcutaneously or Intravenously
  • Postoperative Bleeding
  • GI Bleeding
  • Oncology
  • Postpartum
  • GYN Bleeding

28
Adjuvants to EPO
  • Folic Acid (1 mg/day)
  • Vitamin B-12
  • Ascorbic Acid (500 mg/day)
  • Iron (Oral or Intravenous)

29
Bloodless Medicine and Surgery - Intraoperative
Surgical Management
  • Meticulous Hemostasis
  • Electrocautery
  • Laser Surgery
  • Argon Beam Coagulation
  • Tissue Adhesives
  • Cell Salvage

30
Bloodless Medicine and Surgery - Anesthesia
Management
  • Embolization
  • Positioning of patient
  • Hypotensive anesthesia
  • Induced hypothermia
  • ACUTE NORMOVOLEMIC HEMODILUTION
  • Aprotinin, DDAVP, Tranexamic acid, conjugated
    estrogens

31
Iatrogenic Blood Loss
  • Average ICU Patient can lose 1000 ml or more of
    blood PER WEEK from phlebotomy for laboratory
    testing

32
Routine Blood Testing
  • Routine Blood Tests are often UNECESSARY in
    Patients who refuse transfusion, or if no changes
    in clinical management will result from
    information obtained

33
Transfusion ? Immunomodulation
  • Multiple studies show that transfusion is
    associated with increased risk of earlier cancer
    recurrence, lack of response to cancer treatment,
    and serious postoperative infection.

34
(No Transcript)
35
SHOT - Serious Hazards Of Transfusions
  • 24 month study in UK and Ireland (1996-1998)
  • 424 hospitals surveyed
  • 39 (164) responded
  • Outcome measures
  • Death
  • wrong blood - wrong patient
  • acute and delayed transfusion reactions
  • Acute lung injury
  • Graft vs. host reaction
  • Purpura
  • Infections

36
SHOT - Serious Hazards Of Transfusions
  • 366 major adverse events reported
  • 52 were due to wrong blood to patient
  • 22 total deaths
  • 3 - ABO
  • 12 - infections, 4 - bacterial, 7- viral,
    1 - malaria

37
When does a patient get transfused?
  • Really?

38
(No Transcript)
39
Risks of blood transfusion( Per unit of blood
U.S.A. )
  • Minor allergic reactions 1100
  • Viral hepatitis (A,B,C,D,G) 150,000
  • Hemolytic reactions 16,000
  • Fatal hemolytic reactions 1600,000
  • HIV infection 1420,000
  • HTLV-I/II 1200,000
  • Bacterial infections 12,500
  • Acute lung injury 1500,000
  • Anaphylactic shock 1500,000
  • Graft Vs. host disease Rare
  • Immunosuppression 11

40
Infectious complications
  • Viruses
  • HIV-1,2
  • HTLV-I,II
  • Cytomegalovirus
  • Epstein-Barr virus
  • Parvovirus B19
  • Creutzfeldt-Jakob disease(CJD)
  • TTV
  • West Nile
  • Spirochetes
  • Treponema pallidum
  • Borrelia burgdorferi
  • Parasites
  • Plasmodia
  • Babesia microlti
  • Trypanosoma crizi
  • Toxoplasma gondii
  • Leishmania donovani
  • Bacteria
  • Staphylococcus
  • Salmonella
  • Yersinia enterocolitica

41
To all who received blood fromJanuary 1991 to
December 1996 in aNew York/New Jersey hospital
  • Here is important information from the New York
    Blood Center for anyone who received a
    transfusion of red blood cells, platelets, or
    plasma in a New York or New Jersey hospital
    between January 1991 and December 1996.
  • During that period, there may have been a problem
    with the way New York Blood Center performed
    testing of blood for viral infections. As a
    result, recipients of donated blood products
    during that period may face a potential risk of
    transfusion-transmitted infections, such as HIV
    and hepatitis.

42
Risk versus Benefit
  • Known risks include disease transmission,
    reactions, immunomodulation
  • Benefit of blood unproven
  • Storage dramatically diminishes bloods
    effectiveness as O2 carrier
  • Known risks outweigh perceived benefits

43
What is Acceptable Risk?
  • To patient
  • To physician
  • To society
  • Age-based?
  • Diagnosis-based?

44
Blood Transfusion is Life Saving?
  • NO proof except when used as volume replacement
    in resuscitation
  • There are safer, equally effective alternatives
    such as saline and colloids
  • NO trials that demonstrate better survival from
    blood transfusion

45
NJ Institute of Bloodless Medicine and Surgery
Patient Totals
  • Year pt Mortality
  • 1994 510 0
  • 1995 650 1
  • 1996 1,057 1
  • 1997 1,267 1
  • 1998 1,949 1
  • 1999 2,540 1
  • 2000 2,751 1
  • 2001 3,047 1

46
Range of Low Hgb. Survivors
  • 5 patients lt2.0 gms
  • 16 patients 2.0 - 3.0 gms
  • 25 patients 3.0 - 4.0 gms
  • 69 patients 4.0 - 5.0 gms
  • (4 _at_ 1.7 gms 1 _at_ 1.3 gms!)
  • 11/30/07

47
Clinical Outcomes
  • Our data only
  • January 1997 to June 1999
  • Colectomy
  • Total Hip Arthroplasty
  • Total Knee Arthroplasty
  • Abdominal Hysterectomy

48
Increased Length of Hospital Stay and
CostsTransfused vs. Non Transfused
PatientsSelected Surgical ProceduresEnglewood
Hospital and Medical Center, NJJanuary 1997
June 1999
  • Procedure Average LOS Average Cost (US
    Dollars)
  • Colectomy 1.86 8,300.
  • Total Hip Arthroscopy 0.43 990.
  • Total Knee Arthroscopy 0.43 797.
  • Abdominal Hysterectomy 1.19 6,723.

49
Resources
  • www.bloodlessmed.com
  • www.sabm.org

50
COMMUNICATIONCOOPERATIONNOT CONFRONTATION
51
(No Transcript)
52
  • Thank You !
Write a Comment
User Comments (0)
About PowerShow.com